The latest cancer drugs news
Browsing: Cancer Drug News
Cutting-edge combination shows promise in patients with chemotherapy-resistant urothelial cancer
A combination of two types of cancer-fighting treatments – the immunotherapy agent pembrolizumab and a nanoparticle-bound…
High magnetic field reduces side-effect caused by anti-cancer drug imatinib
In recent research, a group led by Prof Zhang Xin at the High Magnetic Field Laboratory,…
Two drugs reverse key pancreatic cancer step in the lab
Pancreatic cancer often lurks as a silent disease. With no known symptoms, it can progress…
An anticancer rhenium tricarbonyl targets Fe−S cluster biogenesis in ovarian cancer cells
Metal-containing complexes have taken up centre stage in the search for new cancer drugs that are…
Breakthrough in synthesising anti-cancer compound found in Atherton Tablelands
Stanford University researchers (USA) have discovered a rapid and sustainable way to synthetically produce a…
ICR criticises NICE rejection of olaparib for advanced prostate cancer
The Institute of Cancer Research, London, has expressed disappointment that NICE has confirmed its decision…
Lapatinib may boost effectiveness of drugs that destroy cancer proteins by blocking resistance
Researchers have discovered that the drug efflux pump MDR1 promotes resistance to a promising new…
Anti-cancer drug produced by reprogrammed yeast
In the summer and fall of 2019, some cancer patients experienced interruptions in their treatment.…
FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for HER2-mutant non-small cell lung cancer
On August 11, 2022, the Food and Drug Administration granted accelerated approval to fam-trastuzumab deruxtecan-nxki for…
FDA approves capmatinib for metastatic non-small cell lung cancer
On August 10, 2022, the Food and Drug Administration granted regular approval to capmatinib for adult…